Received May 28, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | AMVBO64A | — |
expired dose administered to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received Men ACWY-CRM NVS (Menveo) solution for injection (batch number AMVBO64A with expiry date 31-DEC-2025) for prophylaxis. Previously administered products included Menveo (received first dose on an unknown date). On 11-MAY-2026, the patient received the 2nd dose of Menveo. On 11-MAY-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose administered to a patient).The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date:21-MAY-2026 The patient was administered an expired dose of Menveo 2-vial as the second dose of the series.